
<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0"/>
  <title>LIN 20221231 Analysis</title>
  <link rel="stylesheet" href="styles.css" />
</head>

<body>
  <header>
    <h1>LIN 20221231 Analysis</h1>
  </header>

  <nav>
    <ul>
      <li><a href="#business">üöÄ Business Development</a></li>
      <li><a href="#risk">‚öñÔ∏è Risk and Opportunities</a></li>
      <li><a href="#financials">üìä Financials</a></li>
      <li><a href="#recommend">üìà Recommendation</a></li>
    </ul>
  </nav>

  <main>
    <!-- url -->
    <section id="business" class="module">
      <h2>üîé Source Data</h2>
      <p>
        <!-- Your text goes here. -->
        <a href="https://www.sec.gov/Archives/edgar/data/1707925/000162828023005434/lin-20221231.htm">source filing at SEC</a>
      </p>
    </section>
  
    <!-- Business Development (text only) -->
    <section id="business" class="module">
      <h2>üöÄ Business Development</h2>
      <p>
        <!-- Your text goes here. -->
        - Achieved 8% sales growth in 2022 driven by 7% price increases and 1% volume growth across most end markets, excluding healthcare, supported by new project startups.  <br>- Advanced clean energy initiatives with breakthroughs in blue hydrogen (carbon capture) and green hydrogen (electrolysis) production technologies, positioning as a low-carbon solutions leader.  <br>- Expanded global engineering segment contributions (14% of total sales) through equipment contracts for gas production plants, with $2.8B in 2022 revenue recognized via cost-incurred progress methods.  <br>- Executed productivity initiatives offsetting inflation impacts, reducing SG&A expenses by 3% despite currency headwinds, and improving adjusted operating profit by 10% year-over-year.  <br>- Managed geopolitical risks from Russia-Ukraine conflict via deconsolidation of subsidiaries and $1.0B impairment charges, maintaining adjusted financial growth excluding these one-time impacts.  <br>- Strengthened leadership with appointment of new CEO Sanjiv Lamba in March 2022, emphasizing operational efficiency and strategic focus on high-growth industrial gas applications.  <br>- Enhanced talent pipeline through diversity programs (28% female workforce) and variable compensation aligned with financial and ESG performance metrics, supporting employee retention.  <br>- Leveraged long-term contracts with energy/feedstock cost pass-through provisions, ensuring stable cash flows despite volatile commodity markets.  <br>- Increased R&D investments in proprietary air separation and process gas technologies, maintaining competitive edge in electronics, healthcare, and sustainable energy sectors.  <br>- Optimized capital allocation with $5.1B in share repurchases and $3.2B in capex, prioritizing hydrogen infrastructure and APAC/EMEA market expansions.
      </p>
    </section>

    <!-- Risk and Opportunities (text only) -->
    <section id="risk" class="module">
      <h2>‚öñÔ∏è Risk and Opportunities</h2>
      <p>
        <!-- Your text goes here. -->
        Risks:  <br>- $5.7B net deferred tax liabilities with increased valuation allowances, signaling uncertainty in asset realization.  <br>- $33B non-US subsidiaries' earnings potentially subject to additional taxes if repatriated or sold.  <br>- $325M unrecognized tax benefits and ongoing audits in multiple jurisdictions risking future liabilities.  <br>- Legal contingencies, including $240M exposure in Brazil tax disputes and Russian arbitration impacting contracts.  <br>- Rising valuation allowances ($276M) and $1.5B purchase accounting impacts from merger affecting earnings stability.  <br><br>Opportunities:  <br>- Diversified end-markets (healthcare, electronics, energy) and global operations mitigate cyclical industry risks.  <br>- Long-term contracts with cost pass-through clauses stabilize cash flows ($8.9B operating cash flow in 2022).  <br>- Engineering segment growth ($2.8B sales) and strategic projects in hydrogen/clean energy sectors.  <br>- Productivity initiatives drove 10% adjusted operating profit growth ($7.9B) despite inflationary pressures.  <br>- Strong liquidity ($5.4B cash) supports dividends, share buybacks ($5.1B), and capital investments ($3.2B).
      </p>
    </section>

    <!-- Financials (with 4 image cards + 5 horizontal sections of text) -->
    <section id="financials" class="module">
      <h2>üìä Financials</h2>

      <!-- Four cards with images (responsive layout) -->
      <div class="card-container">
        <div class="card">
          <img src="LIN_20221231_1.jpg" alt="Financial Chart 1" />
        </div>
        <div class="card">
          <img src="LIN_20221231_2.jpg" alt="Financial Chart 2" />
        </div>
        <div class="card">
          <img src="LIN_20221231_3.jpg" alt="Financial Chart 3" />
        </div>
        <div class="card">
          <img src="LIN_20221231_4.jpg" alt="Financial Chart 4" />
        </div>
      </div>

      <!-- 5 horizontal sections (each a text paragraph) -->
      <section class="horizontal-section" id="key-items">
        <h3>Key Items</h3>
        <p>
          <!-- Your text goes here. -->
          - Russia-Ukraine conflict and other charges rose from 0.9% to 3.1% of total revenue (2021-2022), a +2.2 percentage point shift.  <br>- Depreciation and amortization decreased from 15.1% to 12.6% of total revenue, a -2.5 percentage point reduction.  <br>- Basic EPS from continuing operations grew 12.3% ($7.39 to $8.30), while diluted EPS increased 12.6% ($7.32 to $8.23).  <br>- Treasury shares as a proportion of total equity fell over 5% (-12.05% to -18.50% of total liabilities & equity).  <br>- Total assets declined 2.38% ($81,605 to $79,658), total liabilities rose 5.82% ($36,164 to $38,271), and shareholders' equity dropped 8.92% ($45,428 to $41,374).  <br>- Year-over-year asset/liability/equity changes remained below the 10% significance threshold despite directional shifts.  <br>- Increased geopolitical charges and EPS growth occurred alongside declining asset/equity positions and rising liabilities.
        </p>
      </section>

      <section class="horizontal-section" id="profitability-analysis">
        <h3>Profitability Analysis</h3>
        <p>
          <!-- Your text goes here. -->
          - Net Profit Margin remained stable at 12.4% (2022 vs. 2021), reflecting consistent net income relative to sales despite cost pressures.  <br>- Operating Profit Margin slightly declined (16.1% vs. 16.2%), indicating minor operating efficiency challenges, offset by improved cost management (operating expense ratio fell to 25.6% from 26.8%).  <br>- ROA increased to 5.21% (from 4.69%), driven by enhanced asset utilization and stronger internal controls over financial reporting.  <br>- ROE rose to 10.01% (from 8.42%) due to improved equity efficiency, profitability, and share repurchases.  <br>- Gross Profit Margin decreased to 41.7% (from 43.0%), attributed to higher cost of sales and pricing pressures.  <br>- Operating Expense Ratio improved (25.6% vs. 26.8%) as selling, general, and administrative expenses decreased relative to sales.  <br>- Revenue recognition methods (cost incurred input model) introduced variability via cost estimates at completion, flagged as a critical audit matter.  <br>- Management‚Äôs effective internal controls and PwC audit verification bolstered credibility of reported financial improvements.  <br>- Gross margin challenges were partially mitigated by operational cost discipline, maintaining overall profitability stability.
        </p>
      </section>

      <section class="horizontal-section" id="liquidity-analysis">
        <h3>Liquidity Analysis</h3>
        <p>
          <!-- Your text goes here. -->
          - Current ratio improved to 0.79 (2022) from 0.75 (2021), reflecting higher cash reserves ($5.4B vs. $2.8B) and better current liability management, though remaining below 1 signals ongoing short-term coverage challenges.  <br>- Quick ratio rose to 0.61 from 0.55, driven by increased liquid assets excluding inventories, but sub-1 levels indicate reliance on non-liquid assets for obligations.  <br>- Cash ratio increased to 0.33 from 0.21 due to doubled cash equivalents, yet insufficient to fully cover short-term debts without external financing.  <br>- Derivative instruments (interest rate swaps, currency contracts) stabilized cash flows through risk hedging, supporting liquidity improvements.  <br>- Debt structure optimization via higher fixed-rate debt proportion improved interest payment predictability, though total debt growth poses future liquidity risks.  <br>- All ratios below 1 highlight persistent liquidity constraints despite progress, requiring further strengthening of cash reserves and liability management.
        </p>
      </section>

      <section class="horizontal-section" id="solvency-analysis">
        <h3>Solvency Analysis</h3>
        <p>
          <!-- Your text goes here. -->
          - Debt-to-Equity ratio increased from 0.796 (2021) to 0.925 (2022) due to ‚Ç¨2.05B debt issuance (including ‚Ç¨500M 2027 notes, ‚Ç¨750M 2031 notes, and ‚Ç¨800M 2035 notes), raising financial risk through higher leverage.  <br>- Interest Coverage ratio improved from 64.75 to 85.22 as EBIT remained stable at $5,369M while interest expense decreased from $77M to $63M, enhancing debt service capacity.  <br>- Equity ratio declined from 55.7% to 52% as total assets remained flat at $79,658M and equity decreased slightly from $41,374M, reflecting greater debt reliance despite stable asset levels.  <br>- Total liabilities grew through strategic debt financing, while equity reduction suggests retained earnings or share repurchases contributed to lower equity base.  <br>- Improved interest cost management (33% interest expense reduction) offset rising leverage risks, maintaining strong solvency despite increased debt-to-equity and lower equity ratio.  <br>- Company demonstrates effective balance between leveraging growth opportunities (via debt issuance) and maintaining operational earnings to service obligations, though long-term debt sustainability requires monitoring.
        </p>
      </section>

      <section class="horizontal-section" id="efficiency-analysis">
        <h3>Efficiency Analysis</h3>
        <p>
          <!-- Your text goes here. -->
          - Cash Conversion Cycle (CCC) increased from 16.5 days (2021) to 30.7 days (2022), driven by slower inventory turnover (DIO rose from 36.0 to 37.1 days) and reduced supplier payment periods (DPO fell from 72.8 to 56.2 days).  <br>- Improved receivables collection (DSO decreased from 53.3 to 49.8 days) was offset by inventory challenges linked to long-term on-site plant contracts (Note 19) and accelerated supplier payments.  <br>- DPO decline reflects tighter cash management, potentially influenced by increased short-term debt (Note 11) and reduced net operating cash flow from working capital changes.  <br>- Inventory management inefficiencies and shorter payment terms to suppliers were primary contributors to the CCC deterioration, despite better accounts receivable performance.  <br>- Linde's liquidity position was impacted by quicker settlement of payables, reducing cash reserves, while inventory turnover slowed due to operational constraints in distribution methods.
        </p>
      </section>
    </section>

    <!-- Recommendation (text only) -->
    <section id="recommend" class="module">
      <h2>üìà Recommendation:  ‚úÖ  BUY</h2>
      <p>
        <!-- Your text goes here. -->
        Linde plc has shown consistent sales growth and improving profitability metrics such as ROA and ROE. Despite challenges like increasing costs and a higher debt-to-equity ratio, the company's strong cash position and efficient cost management suggest continued growth in EPS. Share buybacks and improved net income also support this positive outlook.
      </p>
    </section>
  </main>

  <footer>
    <p>¬© 2025 SnapStock Report</p>
  </footer>
</body>
</html>


